First Time Loading...

ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 6.67 USD 0.76%
Updated: May 2, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

144.5m
-3%
Assets
Growth Rates:
1 Year
-12%
3 Years
+90%
5 Years
+995%
7 Years
+803%
10 Years
-
3.8m
+9%
Liabilities
Growth Rates:
1 Year
+27%
3 Years
+81%
5 Years
-41%
7 Years
-74%
10 Years
-
140.7m
-3%
Equity
Growth Rates:
1 Year
-13%
3 Years
+90%
5 Years
+1 969%
7 Years
+9 279%
10 Years
-

Balance Sheet Decomposition
ESSA Pharma Inc

144.5m
Assets
3.8m
Liabilities
144.5m
Assets
3.8m
Liabilities
Current Assets 143.9m
Cash & Short-Term Investments 142.1m
Receivables 180.6k
Other Current Assets 1.6m
Non-Current Assets 620.4k
PP&E 363.2k
Other Non-Current Assets 257.2k
Current Liabilities 3.5m
Accounts Payable 2.6m
Accrued Liabilities 930.7k
Non-Current Liabilities 275.4k
Other Non-Current Liabilities 275.4k

Balance Sheet
ESSA Pharma Inc

Rotate your device to view
Balance Sheet
Currency: USD
Sep-2013 Sep-2014 Sep-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Sep-2020 Sep-2021 Sep-2022
Assets
Cash & Cash Equivalents
0
4
2
9
4
15
53
56
138
57
Cash
0
4
2
9
4
15
53
56
0
0
Cash Equivalents
0
0
0
0
0
0
0
0
138
57
Short-Term Investments
0
0
0
0
0
0
0
22
57
110
Total Receivables
0
0
4
0
0
0
0
0
1
0
Accounts Receivables
0
0
4
0
0
0
0
0
1
0
Other Receivables
0
0
0
0
0
0
0
0
0
0
Other Current Assets
0
0
2
1
1
1
1
2
2
2
Total Current Assets
0
4
7
10
5
16
54
80
198
169
PP&E Net
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Intangible Assets
0
0
0
0
0
0
0
0
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
1
N/A
4
+500%
8
+79%
10
+39%
6
-46%
16
+186%
55
+241%
81
+48%
198
+146%
170
-14%
Liabilities
Accounts Payable
0
1
2
4
2
1
1
1
1
1
Accrued Liabilities
0
0
0
0
0
0
0
1
3
1
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
2
3
4
0
0
0
Other Current Liabilities
0
0
0
0
0
0
0
0
0
0
Total Current Liabilities
0
1
2
4
4
3
6
1
4
2
Long-Term Debt
0
0
0
0
6
4
0
0
0
0
Other Liabilities
0
2
1
7
0
0
0
0
0
0
Total Liabilities
0
N/A
2
+1 000%
3
+41%
11
+252%
10
-9%
7
-30%
6
-19%
1
-77%
4
+223%
2
-43%
Equity
Common Stock
4
7
19
26
26
40
79
131
277
278
Retained Earnings
4
5
13
24
28
29
58
81
118
153
Additional Paid In Capital
0
0
0
0
0
0
30
31
36
44
Other Equity
0
0
2
2
2
2
2
2
2
2
Total Equity
1
N/A
2
+300%
5
+125%
1
N/A
4
-760%
9
N/A
49
+433%
79
+62%
194
+145%
167
-14%
Total Liabilities & Equity
1
N/A
4
+500%
8
+79%
10
+39%
6
-46%
16
+186%
55
+241%
81
+48%
198
+146%
170
-14%
Shares Outstanding
Common Shares Outstanding
1
1
1
2
2
6
21
32
44
44

See Also

Summary
EPIX intrinsic value, competitors valuation, and company profile.
DCF Valuation
EPIX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EPIX stock valuation using valuation multiples.
Wall Street Estimates
EPIX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EPIX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.